Philadelphia, February 20, 2025 – Endomyocardial biopsy (EMB) is a valuable method for diagnosing a range of cardiac conditions, but there is a risk of complication due to its invasive nature.

Heart biopsy tissue from a patient with COVID-19. New technologies can image the cellular landscape of heart tissue in detail. Heart cell boundaries are stained green, the cell nuclei in blue. A group ...

The diagnosis of cardiac ATTR amyloidosis is frequently missed or delayed due to the transitional requirement that a tissue sample (biopsy) is required to confirm the diagnosis. A nuclear medicine ...

Healio spoke with Joban Vaishnav, MD, director of the Johns Hopkins Comprehensive Amyloidosis Center, about the process of diagnosing amyloidosis, the importance of multidisciplinary care in patients ...

Prospective DEFINE-HT Study Demonstrates that Prospera™ Heart is Predictive of Clinical Outcomes and Outperforms Biopsy in Predicting Graft Dysfunction Prospera Heart with donor quantity score (DQS) ...

SUNNYVALE, Calif. and UTRECHT, Netherlands, Aug. 13, 2025 (GLOBE NEWSWIRE) -- BioCardia (BCDA) ®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...